{"result": {"id": "chatcmpl-226", "choices": [{"finish_reason": "stop", "index": 0, "logprobs": null, "message": {"content": "The **IVA** group, which consisted of patients with **mCNV**, was studied as part of a research project investigating treatment methods.  This group received no intervention in the form of intravitreal injections for the treatment of neovascular age-related macular degeneration (nAMD).  Additionally, the **IVA** term refers to individuals who did not receive either dry macula treatment or IVBr treatment. \n", "refusal": null, "role": "assistant", "annotations": null, "audio": null, "function_call": null, "tool_calls": null}}], "created": 1743288653, "model": "gemma2:2b", "object": "chat.completion", "service_tier": null, "system_fingerprint": "fp_ollama", "usage": {"completion_tokens": 85, "prompt_tokens": 251, "total_tokens": 336, "completion_tokens_details": null, "prompt_tokens_details": null}}, "input": {"messages": [{"content": "\nYou are a helpful assistant responsible for generating a comprehensive summary of the data provided below.\nGiven one or two entities, and a list of descriptions, all related to the same entity or group of entities.\nPlease concatenate all of these into a single, comprehensive description. Make sure to include information collected from all the descriptions.\nIf the provided descriptions are contradictory, please resolve the contradictions and provide a single, coherent summary.\nMake sure it is written in third person, and include the entity names so we have the full context.\n\n#######\n-Data-\nEntities: \"IVA\"\nDescription List: [\"IVA is a person who has been studied in the context of improving vision\", \"The **IVA** group, which received treatment in the study, consists of patients with **mCNV**.  Their treatment method was investigated as part of the study.  Additionally, the **IVA** refers to a group of patients who did not receive either a dry macula treatment or IVBr treatment. These individuals were those who received no intervention in the form of intravitreal injections for the treatment of neovascular age-related macular degeneration (nAMD). \\n\"]\n#######\nOutput:\n", "role": "user"}], "parameters": {"model": "gemma2:2b", "frequency_penalty": 0.0, "max_tokens": 500, "n": 1, "presence_penalty": 0.0, "temperature": 0.0, "top_p": 1.0}}, "key": "chat_summarize_5057b38ed2300030e5dfd81c36c3ae20ca0c3848f1679955fb625130e9312849_v2"}